BeyondSpring Announces Planned Start of Phase I Investigator-Initiated Trial of Plinabulin Plus Nivolumab, Enters Immuno-Oncology Space
15 sept. 2015 10h17 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
Data Supporting BeyondSpring's Lead Asset, Plinabulin, to be Presented at WCLC 2015
01 sept. 2015 09h16 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring to Present Two Posters Supporting Plinabulin at WCLC 2015
31 août 2015 09h31 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications
23 mars 2015 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, March 23, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Files Composition of Matter Patent Application for Plinabulin Combination Therapy in Immuno-Oncology
24 févr. 2015 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 24, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Pharmaceuticals Names Dr. Yan Sun as Principal Investigator for Global Phase 3 Lung Cancer Clinical Trial of Plinabulin
09 déc. 2014 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 9, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, announced that...
BeyondSpring Pharmaceuticals to Conduct Phase 3 Trial of Lead Candidate Plinabulin in NSCLC
03 déc. 2014 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 3, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...